| Name: | Atorvastatin Isopropyl Ester |
| Catalogue No. | VL10028 |
| CAS No. | 1035205-25-4 |
| Molecular Formula | C36H41FN2O5 |
| Molecular Weight | 600.72 g/mol |
| Status | In-Stock |
| IUPAC Name | (3R,5R)-7-[3-(Phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid isopropyl ester |
| Description | Atorvastatin Isopropyl Ester(CAS No: 1035205-25-4)or (3R,5R)-7-[3-(Phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid isopropyl ester,lowering both elevated LDL-cholesterol and triglyceinhibitorrides and decrease intermediate-density lipoprotein. |
| References | McIver, Lindsey A., and Momin S. Siddique. “Atorvastatin.” Nih.gov, StatPearls Publishing, 5 Jan. 2019, www.ncbi.nlm.nih.gov/books/NBK430779/. Ramkumar, Satish, et al. “Statin Therapy: Review of Safety and Potential Side Effects.” Acta Cardiologica Sinica, vol. 32, no. 6, Taiwan Society of Cardiology, 2016, pp. 631–39, https://doi.org/10.6515/ACS20160611A. |
